Dragon's Blood, or Sangre de Grado, is an ancient Amazonian remedy. Contrary to it's name, it is not actual blood. Rather it is the resin sap from the bark of a species of trees called Croton Lechleri which grows around the world. It was used for centuries by indigenous populations in South America to fight off Ulcerative Colitis, diarrhea, skin infections, stomach ulcers, cancer and many respiratory and gastrointestinal problems. Additionally, They used dragon blood to increase the rapidity of the wound healing process. Ancient Roman, Greek, Arab, and Chinese cultures also utilized it's properties. It's therapeutic effects were legendary. For a long time though, the knowledge of dragon blood's health benefits was almost completely forgotten. Fortunately, in recent times, it started to regain some attention.
Now that we understand a bit about it's history, let's examine dragon blood's healing properties.
One placebo controlled clinical study demonstrated dragon blood's wound healing effects on a group of sixty people aged 14 to 65. 30 of them applied dragons blood topically to their wounds. The other 30 applied placebo drops. The patient's healing process was observed by researchers for twenty days. Already from the first day of the trial, the dragon blood group started to experience crusting of the wound, whereas the placebo group didn't experience any wound crusting until the fifth day. The duration of the inflammation process in the blood dragon group was significantly shorter than for the placebo group. By the end of the trial, the dragon blood group was already experiencing late stage wound proliferation (tissue and muscle rebuilding) and early maturation (reattaching and normalizing of the skin), whereas the placebo group's wounds were just starting the proliferation process.
Dragon Blood and Colon Cancer
Dragon blood has also been shown to help people suffering from cancer. In one study in 2002, researchers discovered that by giving cancer patients just three grams of dragon blood daily, gastrointestinal cancer cell growth was significantly inhibited in just under three weeks. The study was published in the Journal of Ethnopharmacology. The study's author commented that dragon blood "should be evaluated further as a potential source of anti-cancer agents."
Another study, from 2012, was conducted on both humans and mice suffering from colon cancer and leukemia. The humans were divided into two groups as well as the mice. The study lasted for six months. Half of the human test subjects and also half the mice, were given dragon blood. The second group of mice received target treatment (conventional cancer treatment), whereas the humans received no treatment at all. The humans and mice were each given doses of dragon blood. After the six months were up, the human-and-mice dragon blood groups had no tumor growth and in most of the cases, significant induced apoptosis. Apoptosis is a type of programmed cell death, necessary for halting the proliferation of cancer cells. On the other hand, the mice from target treatment group did not experience improvement in their condition, and the humans who received no treatment at all actually had increased cancer cell activity.